Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy  (vol 15, 135, 2020): Melanoma brain metastases prognostic score

Jana Schaule; Stephanie G C Kroeze; Oliver Blanck; Susanne Stera; Klaus H Kahl; Falk Roeder; Stephanie E Combs; David Kaul; An Claes; Markus M Schymalla; Sonja Adebahr; Franziska Eckert; Fabian Lohaus; Nasrin Abbasi-Senger; Guido Henke; Marcella Szuecs; Michael Geier; Nora Sundahl; Daniel Buergy; Reinhard Dummer; Matthias Guckenberger

doi:10.1186/s13014-020-01708-y

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (vol 15, 135, 2020): Melanoma brain metastases prognostic score

Jana Schaule, Stephanie G C Kroeze, Oliver Blanck, Susanne Stera, Klaus H Kahl, Falk Roeder, Stephanie E Combs, David Kaul, An Claes, Markus M Schymalla, Sonja Adebahr, Franziska Eckert, Fabian Lohaus, Nasrin Abbasi-Senger, Guido Henke, Marcella Szuecs, Michael Geier, Nora Sundahl, Daniel Buergy, Reinhard DummerMatthias Guckenberger

Department of Radiotherapy

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

3 Downloads (Pure)

Abstract

An amendment to this paper has been published and can be accessed via the original article. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8)

Original language	English
Article number	280
Pages (from-to)	1-2
Journal	Radiation Oncology [E]
Volume	15
Issue number	1
DOIs	https://doi.org/10.1186/s13014-020-01708-y
Publication status	Published - 14 Dec 2020

Access to Document

10.1186/s13014-020-01708-y

s13014-020-01708-yFinal published version, 576 KB

Cite this

Schaule, J., Kroeze, S. G. C., Blanck, O., Stera, S., Kahl, K. H., Roeder, F., Combs, S. E., Kaul, D., Claes, A., Schymalla, M. M., Adebahr, S., Eckert, F., Lohaus, F., Abbasi-Senger, N., Henke, G., Szuecs, M., Geier, M., Sundahl, N., Buergy, D., ... Guckenberger, M. (2020). Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (vol 15, 135, 2020): Melanoma brain metastases prognostic score . Radiation Oncology [E], 15(1), 1-2. Article 280. https://doi.org/10.1186/s13014-020-01708-y

@article{3d37a37beab146afb5e596f506aae250,

title = "Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (vol 15, 135, 2020): Melanoma brain metastases prognostic score ",

abstract = "An amendment to this paper has been published and can be accessed via the original article. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8)",

author = "Jana Schaule and Kroeze, {Stephanie G C} and Oliver Blanck and Susanne Stera and Kahl, {Klaus H} and Falk Roeder and Combs, {Stephanie E} and David Kaul and An Claes and Schymalla, {Markus M} and Sonja Adebahr and Franziska Eckert and Fabian Lohaus and Nasrin Abbasi-Senger and Guido Henke and Marcella Szuecs and Michael Geier and Nora Sundahl and Daniel Buergy and Reinhard Dummer and Matthias Guckenberger",

year = "2020",

month = dec,

day = "14",

doi = "10.1186/s13014-020-01708-y",

language = "English",

volume = "15",

pages = "1--2",

journal = "Radiation Oncology [E]",

issn = "1748-717X",

publisher = "BioMed Central",

number = "1",

}

Schaule, J, Kroeze, SGC, Blanck, O, Stera, S, Kahl, KH, Roeder, F, Combs, SE, Kaul, D, Claes, A, Schymalla, MM, Adebahr, S, Eckert, F, Lohaus, F, Abbasi-Senger, N, Henke, G, Szuecs, M, Geier, M, Sundahl, N, Buergy, D, Dummer, R & Guckenberger, M 2020, 'Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (vol 15, 135, 2020): Melanoma brain metastases prognostic score ', Radiation Oncology [E], vol. 15, no. 1, 280, pp. 1-2. https://doi.org/10.1186/s13014-020-01708-y

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (vol 15, 135, 2020): Melanoma brain metastases prognostic score . / Schaule, Jana; Kroeze, Stephanie G C; Blanck, Oliver et al.
In: Radiation Oncology [E], Vol. 15, No. 1, 280, 14.12.2020, p. 1-2.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (vol 15, 135, 2020)

T2 - Melanoma brain metastases prognostic score

AU - Schaule, Jana

AU - Kroeze, Stephanie G C

AU - Blanck, Oliver

AU - Stera, Susanne

AU - Kahl, Klaus H

AU - Roeder, Falk

AU - Combs, Stephanie E

AU - Kaul, David

AU - Claes, An

AU - Schymalla, Markus M

AU - Adebahr, Sonja

AU - Eckert, Franziska

AU - Lohaus, Fabian

AU - Abbasi-Senger, Nasrin

AU - Henke, Guido

AU - Szuecs, Marcella

AU - Geier, Michael

AU - Sundahl, Nora

AU - Buergy, Daniel

AU - Dummer, Reinhard

AU - Guckenberger, Matthias

PY - 2020/12/14

Y1 - 2020/12/14

N2 - An amendment to this paper has been published and can be accessed via the original article. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8)

AB - An amendment to this paper has been published and can be accessed via the original article. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8)

UR - http://www.scopus.com/inward/record.url?scp=85097586518&partnerID=8YFLogxK

U2 - 10.1186/s13014-020-01708-y

DO - 10.1186/s13014-020-01708-y

M3 - Comment/Letter to the editor

C2 - 33317582

SN - 1748-717X

VL - 15

SP - 1

EP - 2

JO - Radiation Oncology [E]

JF - Radiation Oncology [E]

IS - 1

M1 - 280

ER -

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (vol 15, 135, 2020): Melanoma brain metastases prognostic score

Abstract

Access to Document

Other files and links

Fingerprint

Cite this